price
PH
NASDAQ · PHAR
Pharming Group N.V.
Healthcare · Biotechnology
$9.79
Up+$0.26 (+2.73%)
Updated Oct 11, 2026, 6:15 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.2B
- P/E ratio
- 3,147.1
- Dividend yield
- 0.00%
- 52-week range
- $9.44 – $18.41
- Volume
- 3.33K
- Avg. volume
- 16.7K
Price performance · PHAR
PHAR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
PHAR closed at $9.79 after 20 trading sessions, down 9.52% for the selected period.
- Last close
- $9.79
- Period change
- -9.52%
- Period low
- $9.53
- Period high
- $11.26
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $9.79 | $9.85 | $9.5248 | $9.79 | 3.33K |
| Oct 8, 2026 | $9.65 | $9.7716 | $9.4413 | $9.53 | 5.12K |
| Oct 7, 2026 | $9.65 | $9.75 | $9.59 | $9.65 | 3.83K |
| Oct 6, 2026 | $9.86 | $9.86 | $9.68 | $9.68 | 6.73K |
| Oct 5, 2026 | $9.75 | $10.08 | $9.736 | $9.80 | 10.81K |
| Oct 2, 2026 | $9.95 | $9.9591 | $9.75 | $9.75 | 12.41K |
| Oct 1, 2026 | $10.08 | $10.15 | $9.95 | $9.95 | 12.09K |
| Sep 30, 2026 | $10.16 | $10.28 | $9.99 | $9.99 | 12.32K |
| Sep 29, 2026 | $10.17 | $10.23 | $10.00 | $10.01 | 26.27K |
| Sep 28, 2026 | $10.46 | $10.70 | $10.33 | $10.52 | 15.48K |
| Sep 25, 2026 | $10.42 | $11.15 | $10.25 | $10.46 | 128.55K |
| Sep 24, 2026 | $10.59 | $10.64 | $10.36 | $10.44 | 31.87K |
| Sep 23, 2026 | $11.00 | $11.06 | $10.65 | $10.77 | 28.6K |
| Sep 22, 2026 | $11.11 | $11.48 | $10.9877 | $11.26 | 51.29K |
| Sep 21, 2026 | $10.50 | $11.50 | $10.50 | $10.81 | 218.38K |
| Sep 18, 2026 | $10.72 | $10.75 | $10.50 | $10.55 | 7.85K |
| Sep 17, 2026 | $10.73 | $10.945 | $10.73 | $10.78 | 5.4K |
| Sep 16, 2026 | $10.67 | $10.75 | $10.50 | $10.60 | 58.03K |
| Sep 15, 2026 | $10.82 | $10.83 | $10.4397 | $10.55 | 15.27K |
| Sep 14, 2026 | $10.78 | $11.1926 | $10.72 | $10.82 | 19.68K |
Latest PHAR news
The latest Smart Investors Daily articles mentioning PHAR.
Stock researchCompany · Overview
Company
Market Activity
Research & News
Loading stock research…